本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Vor Biopharma Inc.

23.08
+0.78003.50%
盤後23.090.0100+0.04%19:50 EDT
成交量:88.86萬
成交額:2,055.09萬
市值:13.65億
市盈率:2.00
高:23.56
開:22.39
低:22.27
收:22.30
52周最高:49.95
52周最低:6.50
股本:5,916.23萬
流通股本:3,723.34萬
量比:1.24
換手率:2.39%
股息:- -
股息率:- -
每股收益(TTM):11.53
每股收益(LYR):-70.5015
淨資產收益率:-125.43%
總資產收益率:-21.37%
市淨率:-6.82
市盈率(LYR):-0.33

資料載入中...

2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/11

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/07

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/06

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/30

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/07

重要事件披露

Form 8-K - Current report
2026/06/12

重要事件披露

Form 8-K - Current report
2026/06/08

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/06

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/06

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/05

SEC問詢函

Form CORRESP - Correspondence
2026/04/01

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/03/30

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/30

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/27

重要事件披露

Form 8-K - Current report